Antivirals Global Market To Reach Value Of About $68 Billion In 2025

The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.

Global Antivirals Market Size And Drivers:

The global antivirals market is expected to decline from $62.62 billion in 2020 to $52.13 billion in 2021 at a compound annual growth rate (CAGR) of -16.8%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $67.66 billion in 2025 at a CAGR of 6.7%. Increasing public-private funding for life science research globally is expected to drive the growth of anti-viral drug therapy market.

Request For A Sample For The Global Antivirals Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Trends In The Global Antivirals Market

Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus. Technological advances in the pharmaceutical sector include development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce the vaccine antigen. In March 2020, Applied DNA Sciences’ subsidiary LineaRx and Takis Biotech formed a joint venture to develop a linear DNA vaccine as a treatment for coronavirus. The JV will use Polymerase Chain Reaction (PCR)-based DNA manufacturing technology to develop the vaccine. Such initiatives and activities are projected to support market growth to a significant extent.

Global Antivirals Market Segments:
The global antivirals market is further segmented –
By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others.
By Application: HIV, Hepatitis, Herpes, Influenza, Others.
By Type: Branded, Generic
By Geography: The global antivirals market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Antivirals Market At:

Antivirals Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides antivirals market overviews, analyzes and forecasts market size and growth for the global antivirals market, antivirals market share, antivirals market players, antivirals market segments and geographies, antivirals market’s leading competitors’ revenues, profiles and market shares. The antivirals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.